DBV Technologies (NASDAQ: DBVT) has recently received a number of price target changes and ratings updates: 8/29/2017 – DBV Technologies was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $50.00 price target on the stock. According to Zacks, “DBV Technologies SA is a biopharmaceutical […]